Mirae Asset Global Investments
LXRX icon

Mirae Asset Global Investments’s Lexicon Pharmaceuticals LXRX Stock Holding History

Mirae Asset Global Investments’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,049
Closed -$19K – 1697
2025
Q3 		$19K Buy
14,049
+20
+0.1% +$23 ﹤0.01% 1503
2025
Q2 		$13.3K Buy
14,029
+1,933
+16% +$1.25K ﹤0.01% 1451
2025
Q1 		$6.9K Buy
12,096
+50
+0.4% +$32 ﹤0.01% 1499
2024
Q4 		$9.32K Sell
12,046
-1,028
-8% -$1.24K ﹤0.01% 1521
2024
Q3 		$20.9K Buy
13,074
+2,282
+21% +$4.06K ﹤0.01% 1428
2024
Q2 		$18.8K Buy
+10,792
New +$19.4K ﹤0.01% 1387
2020
Q2 		– Sell
-12,104
Closed -$23K – 1498
2020
Q1 		$23K Hold
12,104
– – ﹤0.01% 1402
2019
Q4 		$50K Buy
12,104
+913
+8% +$3.52K ﹤0.01% 1463
2019
Q3 		$34K Buy
+11,191
New +$34.6K ﹤0.01% 1418
2015
Q2 		– Sell
-2,474
Closed -$16K – 485
2015
Q1 		$16K Buy
2,474
+731
+42% +$4.99K ﹤0.01% 472
2014
Q4 		$11K Buy
1,743
+43
+3% +$347 ﹤0.01% 441
2014
Q3 		$17K Buy
+1,700
New +$18.2K ﹤0.01% 455

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Mirae Asset Global Investments's LXRX Position: Q4 2025 in Review

Mirae Asset Global Investments sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2025, closing a stake of 14,049 shares — an estimated $19K sold.

Mirae Asset Global Investments first reported a position in LXRX in Q3 2014 and held it in 12 quarters. The position peaked at $50K in Q4 2019. 125 funds tracked by Wall St. Rank hold LXRX as of Q4 2025.

  • Mirae Asset Global Investments reported no remaining Lexicon Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 14,049 Lexicon Pharmaceuticals shares in Q4 2025, an estimated $19K.
  • Mirae Asset Global Investments first reported a position in Lexicon Pharmaceuticals in Q3 2014 and held it in 12 quarters.
  • Mirae Asset Global Investments's Lexicon Pharmaceuticals position peaked at $50K in Q4 2019.
  • 125 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2025.

Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.